#cancer_research
Groundbreaking Research from HYD LLC Unveils Deuterium's Role in Cancer Gene Regulation#Cancer_Research#Budapest#Hungary#HYD_LLC#Deuterium_Modulation
Groundbreaking Research from HYD LLC Unveils Deuterium's Role in Cancer Gene Regulation
HYD LLC shares a pivotal study exploring how deuterium levels influence cancer cell gene expression, emphasizing its potential in treatment strategies.
third-news.com
February 13, 2026 at 11:04 PM
Yosemite's $18 Million Grants Transform Early-Stage Cancer Research and Care#United_States#San_Francisco#Cancer_Research#Grants#Yosemite
Yosemite's $18 Million Grants Transform Early-Stage Cancer Research and Care
Yosemite has allocated over $18 million in grants to foster early-stage cancer research and healthcare improvement initiatives.
third-news.com
February 12, 2026 at 3:20 PM
New Research Identifies Key Molecule in Skin Cancer Progression and Immune Evasion#United_States#New_York#Cancer_Research#melanoma#HOXD13
New Research Identifies Key Molecule in Skin Cancer Progression and Immune Evasion
Recent findings reveal how a molecule, HOXD13, drives skin cancer growth while evading immune detection, highlighting potential treatment targets.
third-news.com
February 11, 2026 at 11:20 AM
Unraveling the Complex Interplay of Nerves in Pancreatic Cancer Development#USA#Cancer_Research#pancreatic_cancer#Cold_Spring_Harbor
Unraveling the Complex Interplay of Nerves in Pancreatic Cancer Development
New research reveals how nerve interactions significantly contribute to pancreatic cancer initiation and progression, suggesting novel treatment pathways.
third-news.com
February 9, 2026 at 3:11 PM
r/Nanome u/KeitaWF :

"Making Cancer Research Faster: How Sanavia Oncology Accelerates Cancer Research with Nanome."

"Better Cancer Research - Nanome / Savania."

https://www.reddit.com/r/Nanome/s/QPJTLLVACE

#nanome #cancer_research
February 7, 2026 at 2:13 AM
Innovative Partnership between PharosAI and 10x Genomics Aims to Revolutionize Cancer Research with AI Technology#United_Kingdom#Cancer_Research#Pleasanton,_California #10x_Genomics#PharosAI
Innovative Partnership between PharosAI and 10x Genomics Aims to Revolutionize Cancer Research with AI Technology
PharosAI collaborates with 10x Genomics to leverage AI and spatial biology in creating a vast multimodal cancer dataset, enhancing diagnostic capabilities and treatment options.
third-news.com
February 4, 2026 at 2:43 PM
Tampa General Hospital Set to Host Groundbreaking Cancer Research Symposium in 2026#USA#Cancer_Research#Tampa#Tampa_General_Hospital#USF_Health
Tampa General Hospital Set to Host Groundbreaking Cancer Research Symposium in 2026
In March 2026, Tampa General Hospital and the USF Health Morsani College of Medicine will host the 'Microbes, Genes & Cancer' Symposium, featuring top researchers.
third-news.com
January 27, 2026 at 10:11 PM
Okayama University's Professor Yoshisuke Togashi Receives Prestigious Award for Cancer Research in 2027#Japan#Cancer_Research#Okayama#Okayama_University#Yoshisuke_Togashi
Okayama University's Professor Yoshisuke Togashi Receives Prestigious Award for Cancer Research in 2027
Professor Yoshisuke Togashi from Okayama University has been honored with the 22nd Japan Academy Award for his groundbreaking research on cancer immune evasion.
third-news.com
January 18, 2026 at 8:47 AM
Mark Foundation for Cancer Research Recognizes Emerging Leaders with $3.75 Million for Oncology Innovations#United_States#New_York#Cancer_Research#Mark_Foundation#Emerging_Leader
Mark Foundation for Cancer Research Recognizes Emerging Leaders with $3.75 Million for Oncology Innovations
The Mark Foundation awards five early-career scientists $3.75 million in total to support groundbreaking cancer research, advancing oncology treatment.
third-news.com
January 13, 2026 at 3:55 PM
NYU Langone Health's New Cancer Treatment Protocols Set to Advance Patient Care#United_States#New_York#Cancer_Research#NYU_Langone#Precision_Oncology
NYU Langone Health's New Cancer Treatment Protocols Set to Advance Patient Care
The Perlmutter Cancer Center announces upcoming molecular profiling protocols to enhance cancer treatment monitoring for patients.
third-news.com
January 12, 2026 at 1:45 PM
Johnson & Johnson Honors Dr. Tony Hunter with 2025 Dr. Paul Janssen Award for Cancer Research#USA#Cancer_Research#New_Brunswick#J&J#Tony_Hunter
Johnson & Johnson Honors Dr. Tony Hunter with 2025 Dr. Paul Janssen Award for Cancer Research
Johnson & Johnson proudly announces Dr. Tony Hunter as the recipient of the 2025 Dr. Paul Janssen Award, acknowledging his pioneering contributions to cancer research.
third-news.com
January 8, 2026 at 1:29 PM
Indivumed Deepens Collaboration with University of Rochester for Innovative Cancer Therapies#USA#Cancer_Research#Rochester#URMC#Indivumed
Indivumed Deepens Collaboration with University of Rochester for Innovative Cancer Therapies
Indivumed and the University of Rochester Medical Center are advancing their collaboration for innovative, patient-centered cancer therapies through enhanced data methodologies.
third-news.com
December 11, 2025 at 1:46 PM
Indivumed and University of Rochester's Expanded Collaborative Efforts in Cancer Therapy Discoveries#USA#Cancer_Research#Rochester#URMC#Indivumed
Indivumed and University of Rochester's Expanded Collaborative Efforts in Cancer Therapy Discoveries
Indivumed and the University of Rochester Medical Center deepen their collaboration to advance patient-centric cancer therapies, aiming to accelerate the discovery of innovative treatments.
third-news.com
December 10, 2025 at 3:14 PM
Indivumed Partners with URMC: Pioneering Patient-Centric Cancer Research#Cancer_Research#URMC#Indivumed
Indivumed Partners with URMC: Pioneering Patient-Centric Cancer Research
Indivumed is joining forces with the University of Rochester Medical Center, aiming to enhance cancer therapy discovery through patient-centric methodologies and cutting-edge research.
third-news.com
December 10, 2025 at 1:42 PM
Menarini and Stemline Reveal Phase 2 Data for Elacestrant in Metastatic Breast Cancer#USA#New_York#Cancer_Research#Menarini#Elacestrant
Menarini and Stemline Reveal Phase 2 Data for Elacestrant in Metastatic Breast Cancer
Menarini and Stemline Therapeutics present pivotal Phase 2 results of Elacestrant (ORSERDU®) in ER+/HER2- metastatic breast cancer at the 2025 San Antonio Breast Cancer Symposium.
third-news.com
December 9, 2025 at 5:40 PM